Publications by authors named "Takeo Endo"

Claim this Profile
G
Gender-age-physiology stage and body mass index are useful predictors of nintedanib discontinuation and prognosis in patients with idiopathic pulmonary fibrosis and progressive fibrotic interstitial lung diseases.
Kai Yazaki, Masashi Matsuyama, Hiroaki Satoh, Kunihiko Miyazaki, Naoki Arai, Takeo Endo

BMC Pulm Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated thromboses in non-small cell lung cancer patients with mutation.
Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Takeshi Numata, Takeo Endo

Contemp Oncol (Pozn)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Serum TSLP Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma.
Maho Suzukawa, Ken Ohta, Hiroyuki Tashimo, Osamu Narumoto, Hiroya Hashimoto, Takeo Endo

Allergy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.
Tomonori Makiguchi, Hisashi Tanaka, Kei Morikawa, Aya Hirata, Hidetoshi Itani, Takeo Endo, Makoto Endo

Cancer Treat Res Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.
Mao Fujimoto, Hiroyuki Yasuda, Eri Arai, Makoto Nakajima, Saori Takata, Takeo Endo, Makoto Endoh

Clin Epigenetics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion gene.
Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Shinichiro Okauchi, Takeo Endo

Contemp Oncol (Pozn)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice.
Takeshi Numata, Ryota Nakamura, Toshihiro Shiozawa, Hiroko Watanabe, Shinichiro Okauchi, Takeo Endo

Cancer Diagn Progn· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer.
Satoshi Ano, Norihiro Kikuchi, Shinichiro Okauchi, Takeshi Numata, Ryota Nakamura, Takeo Endo

Anticancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations.
Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Shinichiro Okauchi, Takeo Endo

Tuberk Toraks· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Age and -positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study.
Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Shinichiro Okauchi, Takeo Endo

Anticancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer.
Shusuke Kurihara, Ryota Nakamura, Satoshi Yoneyama, Shiho Takase, Takashi Hatori, Takeo Endo

Anticancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI).
Shinichiro Okauchi, Gen Ohara, Toshihiro Shiozawa, Hiroko Watanabe, Takeshi Numata, Takeo Endo

In Vivo· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI).
Tomohiro Tamura, Takeshi Numata, Hidetoshi Yanai, Ryota Nakamura, Toshihiro Shiozawa, Takeo Endo

Anticancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations in / Gene Expression Are Associated with the Efficacy of Nintedanib and Acute Exacerbation Development in Idiopathic Pulmonary Fibrosis Patients.
Naoki Arai, Masayuki Nakajima, Masashi Matsuyama, Sosuke Matsumura, Kai Yazaki, Takeo Endo

Am J Respir Cell Mol Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit of platinum doublet combination therapy in older adults with advanced non-small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.
Mototsugu Shimokawa, Masaki Kanazu, Ryusei Saito, Masahide Mori, Atsuhisa Tamura, Takeo Endo

Thorac Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.
Yoshihito Kogure, Akiko Kada, Hiroya Hashimoto, Shinji Atagi, Yuichi Takiguchi, Takeo Endo

JTO Clin Res Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring mutation: an observational clinical study.
Saori Takata, Kei Morikawa, Hisashi Tanaka, Hidetoshi Itani, Masashi Ishihara, Takeo Endo, Makoto Endoh

Ther Adv Med Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study).
Maho Suzukawa, Ken Ohta, Yuma Fukutomi, Hiroya Hashimoto, Takeo Endo

Allergol Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting systemic therapy toxicity in older adult patients with advanced non-small cell lung cancer: A prospective multicenter study of National Hospital Organization in Japan.
Masaki Kanazu, Mototsugu Shimokawa, Ryusei Saito, Masahide Mori, Atsuhisa Tamura, Takeo Endo

J Geriatr Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes.
Ryota Nakamura, Satoshi Yoneyama, Rika Tobita, Shusuke Kurihara, Takashi Hatori, Takeo Endo

Anticancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for -mutated Non-small Cell Lung Cancer.
Toshihiro Shiozawa, Takeshi Numata, Tomohiro Tamura, Takeo Endo, Takayuki Kaburagi

Anticancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer Patients.
Kunihiko Miyazaki, Shinya Sato, Takahide Kodama, Takeshi Numata, Takeo Endo

In Vivo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis.
Takeshi Numata, Takeo Endo, Hidetoshi Yanai, Kyoko Ota, Yusuke Yamamoto

In Vivo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon Mutations in Clinical Practice.
Yutaka Yamada, Tomohiro Tamura, Yusuke Yamamoto, Hideo Ichimura, Kenji Hayashihara, Takeo Endo

Anticancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired T790M Mutation.
Kunihiko Miyazaki, Tomohiro Tamura, Takayuki Kaburagi, Kazuhito Saito, Masaharu Inagaki, Takeo Endo

Anticancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis